Form 4: Director Brian P. McKeon Receives Dentsply Sirona RSU Grant

Dentsply Sirona Director Brian P. McKeon was granted 28,887 restricted stock units as part of his compensation package.

Summary

• Director Brian P. McKeon acquired 28,887 shares of Dentsply Sirona common stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on June 3, 2026.
• The RSUs vest in full one year from the date of the grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations or financial strategy.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the equity grant is subject to market volatility and the future performance of Dentsply Sirona stock.

Future Outlook

The RSUs are scheduled to vest in full on June 3, 2027, one year from the grant date.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to ensure long-term alignment between board members and shareholders in the dental technology sector.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is consistent with standard practices among S&P 500 and mid-cap healthcare companies.

Stakeholder Impact

• Shareholders may view the equity grant as a standard alignment of director incentives.

Next Steps

• Vesting of the 28,887 RSUs on June 3, 2027.

Key Dates

Keywords

Dentsply Sirona, XRAY, Form 4, Insider Trading, Restricted Stock Units, Director Compensation